252 related articles for article (PubMed ID: 36516243)
1. Mechanistic insight into female predominance in Alzheimer's disease based on aberrant protein S-nitrosylation of C3.
Yang H; Oh CK; Amal H; Wishnok JS; Lewis S; Schahrer E; Trudler D; Nakamura T; Tannenbaum SR; Lipton SA
Sci Adv; 2022 Dec; 8(50):eade0764. PubMed ID: 36516243
[TBL] [Abstract][Full Text] [Related]
2. S-nitrosation of proteins relevant to Alzheimer's disease during early stages of neurodegeneration.
Seneviratne U; Nott A; Bhat VB; Ravindra KC; Wishnok JS; Tsai LH; Tannenbaum SR
Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4152-7. PubMed ID: 27035958
[TBL] [Abstract][Full Text] [Related]
3. Differential S-nitrosylation of proteins in Alzheimer's disease.
Zahid S; Khan R; Oellerich M; Ahmed N; Asif AR
Neuroscience; 2014 Jan; 256():126-36. PubMed ID: 24157928
[TBL] [Abstract][Full Text] [Related]
4. Global analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology.
Zaręba-Kozioł M; Szwajda A; Dadlez M; Wysłouch-Cieszyńska A; Lalowski M
Mol Cell Proteomics; 2014 Sep; 13(9):2288-305. PubMed ID: 24895380
[TBL] [Abstract][Full Text] [Related]
5. Network analysis of S-nitrosylated synaptic proteins demonstrates unique roles in health and disease.
Stykel MG; Ryan SD
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119720. PubMed ID: 38582237
[TBL] [Abstract][Full Text] [Related]
6. The roles of S-nitrosylation and S-glutathionylation in Alzheimer's disease.
Dyer RR; Ford KI; Robinson RAS
Methods Enzymol; 2019; 626():499-538. PubMed ID: 31606089
[TBL] [Abstract][Full Text] [Related]
7. S-Nitrosylation in Alzheimer's disease.
Zhao QF; Yu JT; Tan L
Mol Neurobiol; 2015 Feb; 51(1):268-80. PubMed ID: 24664522
[TBL] [Abstract][Full Text] [Related]
8. Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease.
Ahmad F; Singh K; Das D; Gowaikar R; Shaw E; Ramachandran A; Rupanagudi KV; Kommaddi RP; Bennett DA; Ravindranath V
Antioxid Redox Signal; 2017 Dec; 27(16):1269-1280. PubMed ID: 28264587
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Bypass Rescues Aberrant S-nitrosylation-Induced TCA Cycle Inhibition and Synapse Loss in Alzheimer's Disease Human Neurons.
Andreyev AY; Yang H; Doulias PT; Dolatabadi N; Zhang X; Luevanos M; Blanco M; Baal C; Putra I; Nakamura T; Ischiropoulos H; Tannenbaum SR; Lipton SA
Adv Sci (Weinh); 2024 Mar; 11(12):e2306469. PubMed ID: 38235614
[TBL] [Abstract][Full Text] [Related]
10. An improved sulfur-nitroso-proteome strategy for global profiling of sulfur-nitrosylated proteins and sulfur-nitrosylation sites in mice.
Yang H; Wang L; Xie Z; Shao S; Wu Y; Xu W; Gu B; Wang B
J Chromatogr A; 2023 Aug; 1705():464162. PubMed ID: 37336129
[TBL] [Abstract][Full Text] [Related]
11. The protein S-nitrosylation of splicing and translational machinery in vascular endothelial cells is susceptible to oxidative stress induced by oxidized low-density lipoprotein.
Xu X; Qiu H; Shi F; Wang Z; Wang X; Jin L; Chi L; Zhang Q
J Proteomics; 2019 Mar; 195():11-22. PubMed ID: 30630120
[TBL] [Abstract][Full Text] [Related]
12. S-Nitrosylation of cathepsin B affects autophagic flux and accumulation of protein aggregates in neurodegenerative disorders.
Kim KR; Cho EJ; Eom JW; Oh SS; Nakamura T; Oh CK; Lipton SA; Kim YH
Cell Death Differ; 2022 Nov; 29(11):2137-2150. PubMed ID: 35462559
[TBL] [Abstract][Full Text] [Related]
13. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.
Haun F; Nakamura T; Shiu AD; Cho DH; Tsunemi T; Holland EA; La Spada AR; Lipton SA
Antioxid Redox Signal; 2013 Oct; 19(11):1173-84. PubMed ID: 23641925
[TBL] [Abstract][Full Text] [Related]
14. S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease.
Bossy B; Petrilli A; Klinglmayr E; Chen J; Lütz-Meindl U; Knott AB; Masliah E; Schwarzenbacher R; Bossy-Wetzel E
J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S513-26. PubMed ID: 20463395
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease.
Wang S; Yang F; Petyuk VA; Shukla AK; Monroe ME; Gritsenko MA; Rodland KD; Smith RD; Qian WJ; Gong CX; Liu T
J Pathol; 2017 Sep; 243(1):78-88. PubMed ID: 28657654
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
17. Protein farnesylation is upregulated in Alzheimer's human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer's model mice.
Jeong A; Cheng S; Zhong R; Bennett DA; Bergö MO; Li L
Acta Neuropathol Commun; 2021 Jul; 9(1):129. PubMed ID: 34315531
[TBL] [Abstract][Full Text] [Related]
18. Effects of postmortem delays on protein composition and oxidation.
ElHajj Z; Cachot A; Müller T; Riederer IM; Riederer BM
Brain Res Bull; 2016 Mar; 121():98-104. PubMed ID: 26791740
[TBL] [Abstract][Full Text] [Related]
19. Terminal complement pathway activation drives synaptic loss in Alzheimer's disease models.
Carpanini SM; Torvell M; Bevan RJ; Byrne RAJ; Daskoulidou N; Saito T; Saido TC; Taylor PR; Hughes TR; Zelek WM; Morgan BP
Acta Neuropathol Commun; 2022 Jul; 10(1):99. PubMed ID: 35794654
[TBL] [Abstract][Full Text] [Related]
20. S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.
Qu J; Nakamura T; Cao G; Holland EA; McKercher SR; Lipton SA
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14330-5. PubMed ID: 21844361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
